Saltar al contenido principal

2 publicaciones etiquetados con "AEDV"

Ver Todas las Etiquetas

2021, a great year for Legit.Health

· 5 min de lectura
Andy Anguilar
CEO at Legit.Health

Legit.Health and AEDV

2021 has been a pivotal year for Legit.Health. The company has grown tremendously out of its humble origins, adding to its roster talented and committed professionals that have put their all to make the next chapter of dermatology possible.

We have been rewarded and recognized for our work by several prestigious medical and business organizations, proving that the faith we put in a modern, value based, medicine is shared by many.

But most importantly, we have reached many more medical centres, and thus patients, all over Europe, allowing us to not only take part in numerous groundbreaking clinical trials, but to help doctors help their patients.

The AEDV celebrates in Bilbao the first major scientific event in dermatology after the pandemic

· 3 min de lectura
Andy Anguilar
CEO at Legit.Health
Alfonso Medela
CAIO at Legit.Health

In an event that will be remembered as a turning point for dermatological science, the 48th congress of the Spanish Academy of Dermatology and Venereology (AEDV) in Bilbao was not only a gathering of minds but also a showcase of cutting-edge advancements in the field. A beacon of progress and resilience, this congress was the first major dermatology event in the post-pandemic era, illustrating the relentless pursuit of medical innovation.

AEDV

Hosting over 300 global experts, this congress became a melting pot of ideas, fostering discussions on pivotal topics like psoriasis and teledermatology. Yolanda Gilaberte, vice president of the AEDV, highlighted the enhanced role of teledermatology accelerated by the pandemic, alongside the prospective transformations brought by artificial intelligence in skin disease identification.

Spotlight on Legit.Health: Advancing Dermatological Care

Among the esteemed participants, Legit.Health emerged as a frontrunner in medical imaging, receiving accolades for its innovative use of deep learning algorithms in the "Automatic calculation of the Psoriasis Area and Severity Index (PASI)." This breakthrough underlines Legit.Health's dedication to enhancing patient care and revolutionizing the diagnosis and management of chronic skin diseases.